Researchers at Stanford have developed an innovative in vivo imaging approach to detect inflammatory responses and monitor disease activity by leveraging immune cells that cross the blood brain barrier (BBB) during inflammation.
Stanford inventors have engineered a method for breath-based cancer detection, which can provide rapid and non-invasive early cancer detection and surveillance.